A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.

Recruiting

Phase 1

Sponsor:

Pfizer

Code:

NCT06447662

Conditions

Carcinoma, Pancreatic Ductal

Colorectal Neoplasms

Carcinoma, Non-Small-Cell Lung

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

PF-07934040

Gemcitabine

Nab-paclitaxel

Cetuximab

Fluorouracil

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information